Aristeia Capital LLC Emergent Bio Solutions Inc. Transaction History
Aristeia Capital LLC
- $2.75 Billion
- Q2 2024
A detailed history of Aristeia Capital LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Aristeia Capital LLC holds 94,163 shares of EBS stock, worth $685,506. This represents 0.02% of its overall portfolio holdings.
Number of Shares
94,163
Previous 144,788
34.96%
Holding current value
$685,506
Previous $366,000
75.41%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding EBS
# of Institutions
154Shares Held
30.2MCall Options Held
137KPut Options Held
706K-
Black Rock Inc. New York, NY3.84MShares$28 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$26.7 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.17MShares$23.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.24MShares$9.04 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny946KShares$6.89 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $363M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...